Expectations and the allocation of research and development resources
F. M. Scherer, Harry R. Woltman: Comm. S. 46-52
Gespeichert in:
Veröffentlicht in: | Drugs and health |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , |
Format: | UnknownFormat |
Veröffentlicht: |
1981
|
Schlagworte: | |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Titel | Jahr | Verfasser |
---|---|---|
Physician prescribing behavior : is there learning by doing? | 1981 | Temin, Peter |
Pharmaceutical innovation, product imitation, and public policy | 1981 | Wu, S. Y. |
Price and quality competition in drug markets : evidence from the United States and the Netherlands | 1981 | Reekie, W. Duncan |
Reducing the drug lag : entrepreneurship in pharmaceutical clinical testing | 1981 | Clarkson, Kenneth W. |
Expectations and the allocation of research and development resources | 1981 | Virts, John R. |
The determinants of research and development expenditures in the pharmaceutical industry | 1981 | Grabowski, Henry G. |
The pharmaceutical research and development decision process | 1981 | Wiggins, Steven N. |
Some economic consequences of technological advance in medical care : the case of a new drug | 1981 | Geweke, John F. |
The effect of patent expiration on the market position of drugs | 1981 | Statman, Meir |
The market for research and development : physician demand and drug company supply | 1981 | Telser, Lester G. |